Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

V559A and N822I double KIT mutant melanoma with predictable response to imatinib?

Pigment cell & melanoma research - 1 Apr 2011

McDonnell Kevin, Betz Bryan, Fullen Douglas, Lao Christopher D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Drug Resistance, Neoplasm
Share to Fatal Outcome
Share to Imatinib Mesylate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Piperazines

Share to Proto-Oncogene Proteins c-kit

Share to Pyrimidines

Source

Identifiers

PMID: 21159146
DOI: 10.1111/j.1755-148X.2010.00822.x

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

V559A and N822I double KIT mutant melanoma with predictable response to imatinib?PMID 21159146Read ↗

KIT mutations in a series of melanomas and their impact on treatment with imatinib.Semantic proximity Read ↗

Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma.Semantic proximity Read ↗

Functional and sensitivity profiling of the <i>KIT</i> Mutation Landscape in MelanomaSemantic proximity Read ↗

Clinical and genomic correlates of imatinib response in melanomas with KIT alterations.Semantic proximity Read ↗

KIT and Melanoma: Biological Insights and Clinical Implications.Semantic proximity Read ↗

Another Option in Our KIT of Effective Therapies for Advanced MelanomaSemantic proximity Read ↗

Major response to imatinib mesylate in KIT-mutated melanoma.Semantic proximity Read ↗

Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report.Semantic proximity Read ↗

Assessment of BRAF and KIT mutations in Japanese melanoma patientsSemantic proximity Read ↗

Imatinib in c-KIT-mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18-05 Trial).Semantic proximity Read ↗

Lymph node metastatic melanoma from ungual melanoma: Identification of somatic mutations in KIT and LZTR1.Semantic proximity Read ↗

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.